Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension
- PMID: 11304505
- DOI: 10.1161/01.hyp.37.4.1069
Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension
Abstract
We examined the relation of serum creatinine and uric acid to mortality and cardiovascular disease in older (aged >/=60 years) Chinese patients with isolated systolic hypertension (systolic/diastolic blood pressure >/=160/<95 mm Hg). We used Cox regression to correlate outcome with baseline serum creatinine and uric acid measured in 1880 and 1873, respectively, of the 2394 patients enrolled in the placebo-controlled Systolic Hypertension in China (Syst-China)
Trial: Median follow-up was 3 years. In multiple Cox regression analysis with adjustment for gender, age, active treatment, and other significant covariates, serum creatinine was significantly associated with a worse prognosis. The relative hazard rates (95% CIs) associated with a 20-micromol/L increase in serum creatinine for all-cause, cardiovascular, and stroke mortality were 1.16 (1.05 to 1.27, P=0.003), 1.15 (1.01 to 1.31, P=0.03), and 1.37 (1.13 to 1.65, P=0.001), respectively. In a similar analysis, which also accounted for serum creatinine, serum uric acid was also significantly and independently associated with excess mortality of cardiovascular disease and stroke. The relative hazard rates associated with a 50-micromol/L increase of serum uric acid were 1.14 (1.02 to 1.27, P=0.02) for cardiovascular mortality and 1.34 (1.14 to 1.57, P<0.001) for fatal stroke. In conclusion, in older Chinese patients with isolated systolic hypertension, serum creatinine and serum uric acid were predictors of mortality.
Similar articles
-
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.J Hypertens. 1998 Dec;16(12 Pt 1):1823-9. doi: 10.1097/00004872-199816120-00016. J Hypertens. 1998. PMID: 9869017 Clinical Trial.
-
Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.Arch Intern Med. 2000 Jan 24;160(2):211-20. doi: 10.1001/archinte.160.2.211. Arch Intern Med. 2000. PMID: 10647760 Clinical Trial.
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Lancet. 1997 Sep 13;350(9080):757-64. doi: 10.1016/s0140-6736(97)05381-6. Lancet. 1997. PMID: 9297994 Clinical Trial.
-
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.Minerva Cardioangiol. 2002 Jun;50(3):169-74. Minerva Cardioangiol. 2002. PMID: 12107398 Review.
-
Implications of the Systolic Hypertension in China trial.Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):499-505. doi: 10.3109/10641969909060983. Clin Exp Hypertens. 1999. PMID: 10423076 Review.
Cited by
-
Relationship between silent brain infarction and chronic kidney disease.Nephrol Dial Transplant. 2009 Jan;24(1):201-7. doi: 10.1093/ndt/gfn419. Epub 2008 Aug 12. Nephrol Dial Transplant. 2009. PMID: 18697797 Free PMC article.
-
The relationship between serum levels of uric acid and prognosis of infection in critically ill patients.World J Emerg Med. 2012;3(3):186-90. doi: 10.5847/wjem.j.issn.1920-8642.2012.03.005. World J Emerg Med. 2012. PMID: 25215061 Free PMC article.
-
Development and validation of the Surgical Outcome Risk Tool (SORT).Br J Surg. 2014 Dec;101(13):1774-83. doi: 10.1002/bjs.9638. Br J Surg. 2014. PMID: 25388883 Free PMC article.
-
Association between mortality and serum uric acid levels in non-diabetes-related chronic kidney disease: An analysis of the National Health and Nutrition Examination Survey, USA, 1999-2010.Sci Rep. 2020 Oct 16;10(1):17585. doi: 10.1038/s41598-020-74747-w. Sci Rep. 2020. PMID: 33067501 Free PMC article.
-
The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.Cardiovasc Psychiatry Neurol. 2009;2009:282059. doi: 10.1155/2009/282059. Epub 2009 Nov 4. Cardiovasc Psychiatry Neurol. 2009. PMID: 20029618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical